Observatory · observe first
AbbVie
ABBV · United States · Biotechnology · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
0.400%
12M weight contribution
-0.622 pp
3M weight contribution
-0.454 pp
12M price return
-28.4%
Share of matched S&P 500 members
Monthly observations through Oct 2018
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Oct 2018 | $117.9bn | 0.400% | -0.622 pp | -28.4% | No |
| Sep 2018 | $143.2bn | 0.456% | -0.566 pp | -14.0% | No |
| Aug 2018 | $145.3bn | 0.469% | -0.553 pp | -12.7% | No |
| Jul 2018 | $146.4bn | 0.854% | -0.168 pp | -16.1% | No |
| Jun 2018 | $147.0bn | 0.892% | -0.130 pp | -16.6% | No |
| May 2018 | $157.0bn | 0.953% | -0.069 pp | -10.9% | No |
| Apr 2018 | $153.3bn | 0.942% | -0.080 pp | -13.1% | No |
| Mar 2018 | $150.3bn | 0.922% | -0.100 pp | -15.7% | No |
| Feb 2018 | $183.9bn | 1.102% | +0.080 pp | +3.2% | Yes |
| Jan 2018 | $179.2bn | 1.022% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.